Skip to Content

Join the 'Pediatrics' group to help and get support from people like you.

Pediatrics News

Related terms: Pediatrician

Many Parents Unaware of Emergency Plans at Kids' Pre-schools

Posted 30 Oct 2015 by

FRIDAY, Oct. 30, 2015 – Many American parents don't know if their pre-school or child care facility has an emergency plan in place, a new poll finds. Thirty-nine percent of parents with kids aged 5 and younger said their child's pre-school or day care had an emergency during the past two years due to severe weather, a power outage, an evacuation or a violent situation. But only 37 percent of ...

Breast Milk Bought Online Might Contain Cow's Milk, Study Finds

Posted 6 Apr 2015 by

MONDAY, April 6, 2015 – Parents who buy breast milk online may not always get 100 percent human milk. A new study found about 10 percent of samples tested were contaminated with cow's milk. "Human milk may be purposely 'topped off' with cow's milk or infant formula, and this could be harmful to babies receiving the purchased milk if they have cow's milk allergy or intolerance," said lead author ...

FDA Approves Cholbam (cholic acid) for Rare Bile Acid Synthesis Disorders

Posted 17 Mar 2015 by

March 17, 2015 – Today the U.S. Food and Drug Administration approved Cholbam (cholic acid) capsules, the first FDA approved treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for patients with peroxisomal disorders (including Zellweger spectrum disorders). Patients with these rare, genetic, metabolic conditions exhibit manifestations ...

FDA Approves Unituxin (dinutuximab) for Pediatric High-Risk Neuroblastoma

Posted 10 Mar 2015 by

On March 10, 2015, the U. S. Food and Drug Administration approved dinutuximab (Unituxin, United Therapeutics Corporation), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, ...

Ask a Question